Abstract
AbstractOver the past decade, cord blood (CB) has been established as an alternative source of donor cells for allogeneic hematopoietic stem cell transplantation. The outcome of CB transplants, particularly in children, is similar to the unrelated donor transplants using bone marrow cell or mobilized peripheral blood progenitor cells [1-4]. Early experience in adult CB transplantation was hampered by poor engraftment and immune recovery [5-7]. Recent experiences with better risk patients, double CB unit transplants, and submyeloablative preparative regimens have been more encouraging [8-10].KeywordsCord BloodUnrelated DonorCord Blood TransplantationCell DoseTransplant OutcomeThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
